Tax Filing for Swiss Companies in India
Swiss companies have a long and substantial presence in India. Nestle India has operated since 1961. Novartis, Roche, ABB, Holcim (through Ambuja Cements and ACC), Zurich Insurance, Credit Suisse (now UBS), and Sika all run significant Indian operations. Switzerland consistently ranks among India's top 10 FDI source countries.
A Swiss company operating in India through a wholly-owned subsidiary is taxed as an Indian domestic company. Under section 200 read with section 205(1) of the Income-tax Act, 2025 (section 115BAA of the Income-tax Act, 1961), the effective tax rate is 25.17% (22% plus surcharge and cess). New manufacturing companies incorporated after October 1, 2019, and that commenced manufacturing on or before 31st March 2024 could opt for the lower 15% rate (effective 17.16%) under Section 115BAB. However, this scheme expired on 31st March 2024 and has not been extended; new manufacturing companies can no longer claim this benefit as of 2026.
If the Swiss entity operates through a branch office or project office, it is taxed as a foreign company at 35% plus surcharge and cess (effective ~38.22%). Swiss companies with a permanent establishment in India are taxed on income attributable to that PE.
Every Swiss entity earning income in India must obtain a Permanent Account Number (PAN). The annual income tax return is filed using ITR-6 by October 31 (for audited companies) or November 30 (if transfer pricing Form 48 (formerly Form 3CEB) applies). All foreign-owned companies in India require a mandatory statutory audit.
Switzerland and India also maintain a Bilateral Investment Treaty (BIT) that provides investment protection, though India has been renegotiating its BIT program based on the 2016 Model BIT text.
How Switzerland's DTAA Affects Tax Filing
The India-Switzerland DTAA has been in force since 1994. On December 11, 2024, Switzerland announced that it would stop applying the Most Favored Nation (MFN) clause on its own, for dividends due from January 1, 2025. This did not change withholding tax rates for Swiss companies operating in India.
The MFN Clause: Why 5% Was Never Available in India
From 2021, Switzerland applied a reduced 5% rate to Swiss dividends paid to Indian residents, for income due from 2018, based on the MFN clause. The MFN clause provided that if India signed a treaty with another OECD country offering lower rates, the lower rates would apply to the India-Switzerland treaty as well.
In October 2023, the Indian Supreme Court ruled (in the Nestle SA case) that MFN benefits under tax treaties require explicit notification by the Indian government under the Income Tax Act. Without such notification, MFN benefits cannot be claimed in India. India therefore never applied the 5% rate. Because the treatment was not reciprocal, Switzerland stopped applying the clause unilaterally for dividends due from January 1, 2025.
The practical impact for Swiss investors in India: none. Dividends from Indian companies to Swiss shareholders have been withheld at the 10% treaty rate throughout.
| Income Type | DTAA Rate (Before Jan 2025) | DTAA Rate (From Jan 2025) | Domestic Rate |
|---|---|---|---|
| Dividends | 10% | 10% | 20% |
| Interest | 10% | 10% | 20% |
| Royalties | 10% | 10% | 20% |
| Fees for Technical Services | 10% | 10% | 20% |
No rate on payments from India changed. Switzerland's change affects only Swiss dividends paid to Indian residents, which went back from 5% to 10%.
Dividend distributions from Indian subsidiaries to Swiss parents carry 10% withholding whether declared before or after January 1, 2025.
To claim DTAA benefits, the Swiss entity must provide a Tax Residency Certificate (TRC) from the cantonal tax office in Switzerland, along with Form 41 (formerly Form 10F) filed electronically on the Indian Income Tax portal. Surcharge and cess are not levied on top of treaty rates.
Document Requirements from Switzerland
Switzerland has been a member of the Hague Apostille Convention since 1973 (specifically March 11, 1973). Apostille services are handled by cantonal authorities (the Staatskanzlei of the relevant canton). The Federal Department of Foreign Affairs handles apostilles for documents issued by federal authorities.
For tax filing purposes, the following documents are required from the Swiss parent entity:
- Tax Residency Certificate (TRC): Issued by the cantonal tax office (Steueramt/Administration fiscale) of the canton where the Swiss entity is resident. Must be renewed annually and valid for the relevant Indian assessment year. Processing typically takes 5-10 working days.
- Form 41: Self-declaration form filed electronically on the Indian Income Tax portal. Must include the Swiss entity's identification number (UID/IDE number), address, and entity status.
- Apostilled corporate documents: Handelsregisterauszug (commercial register extract), articles of association (Statuten), and board resolutions. Apostilled by the cantonal Staatskanzlei.
- Transfer pricing documentation: Detailed documentation under Section 171 of the Income-tax Act, 2025 (section 92D of the Income-tax Act, 1961) for all intercompany transactions. Swiss pharmaceutical, chemicals, and engineering companies typically have complex intercompany arrangements including royalty payments, management fees, and cost-sharing agreements. Form 48 must be filed by October 31, a month ahead of the November 30 return deadline.
- Swiss parent financial statements: May be required during transfer pricing assessments. Swiss companies follow Swiss GAAP FER or IFRS. English translations should be apostilled.
Documents in German, French, or Italian must be accompanied by certified English translations. Apostille processing through cantonal authorities typically takes 3-7 working days.
Step-by-Step Tax Filing Process
Step 1: Year-End Book Closure
Close the Indian subsidiary's books as of March 31. Swiss companies typically follow a December or March year-end for their group reporting. Regardless, the Indian subsidiary must prepare financial statements for the April-March Indian fiscal year. Reconcile all intercompany balances with the Swiss parent.
Step 2: Statutory Audit
Engage a chartered accountant for the mandatory statutory audit. File the audit report in Form 3CA/3CD on the Income Tax portal. For companies with net worth above Rs 250 crore (common for large Swiss subsidiaries like Nestle India or ABB India), Indian Accounting Standards (Ind AS) apply.
Step 3: Transfer Pricing Study
Prepare comprehensive transfer pricing documentation for all intercompany transactions with the Swiss parent and other group entities. This includes sale/purchase of goods, royalty payments, management fees, interest on intercompany loans, cost-sharing arrangements, and guarantee fees. File Form 48 by October 31, a month before the November 30 return deadline.
Swiss pharmaceutical and chemical companies face particular scrutiny on royalty rates. Indian tax authorities have challenged royalty payments exceeding 2-4% of net sales in several high-profile cases involving Swiss pharma companies.
Step 4: Obtain TRC from Cantonal Tax Office
Request the TRC from the relevant cantonal Steueramt. Allow 5-10 working days for processing. Upload to the Indian Income Tax portal along with Form 41. Verify that the TRC covers the correct Indian assessment year.
Step 5: Apply the 10% Dividend Rate
Apply the 10% DTAA withholding rate to dividends paid to the Swiss parent. Review any interim dividends declared during FY 2024-25 to verify that 10% was applied; India never allowed the 5% MFN rate on dividends paid to Swiss shareholders.
Step 6: Compute Tax and File ITR-6
Calculate total income, apply the appropriate corporate tax rate, claim DTAA benefits on cross-border payments, and file ITR-6 by October 31 (or November 30 with Form 48). Ensure all TDS credits and advance tax payments are properly accounted for.
Step 7: GST Compliance
File monthly GST returns (GSTR-3B and GSTR-1). If the Swiss parent provides services to the Indian subsidiary, GST at 18% is payable under the reverse charge mechanism. This commonly applies to management fees, technical assistance, IT support, and brand licensing from the Swiss parent.
Step 8: FEMA and Repatriation Compliance
File the Annual Return on Foreign Liabilities and Assets (ARFLA) with the RBI by July 15. For profit repatriation, deduct TDS at the applicable DTAA rate (10% on dividends from January 2025), file Form 145/146 (formerly Form 15CA/15CB), and process through the Authorized Dealer bank.
Timeline and Costs
| Filing | Deadline | Estimated Cost (INR) |
|---|---|---|
| Advance Tax (4 installments) | Jun 15, Sep 15, Dec 15, Mar 15 | Based on estimated liability |
| GST Returns (monthly) | 20th of following month | 25,000-1,50,000/year |
| TDS Returns (quarterly) | Within 31 days of quarter end | 30,000-1,00,000/year |
| Statutory Audit (Form 3CA/3CD) | Before ITR due date | 2,00,000-15,00,000 |
| Transfer Pricing Report (Form 48) | October 31 | 3,00,000-20,00,000 |
| Income Tax Return (ITR-6) | October 31 / November 30 | 75,000-5,00,000 |
| FEMA/RBI Returns (ARFLA) | July 15 | 25,000-75,000 |
Costs for large Swiss multinational subsidiaries (Nestle, ABB, Novartis) are at the higher end, reflecting the complexity of their operations, multiple business segments, and extensive intercompany transactions. Mid-sized Swiss companies operating in India can expect costs in the middle range.
The overall timeline from year-end close to final ITR filing is approximately 5-8 weeks. Factor in time for obtaining the TRC from the cantonal tax office (5-10 working days).
Common Challenges for Swiss Companies
MFN Clause: A Common Misreading
Many summaries of the December 2024 announcement say Swiss investors in India now face 10% instead of 5%. That is not correct: India never applied the 5% rate, and the Swiss government has said the change has no effect on Swiss investment in India. The Swiss government cited the Indian Supreme Court's October 2023 ruling in the Nestle SA case and the lack of reciprocity as the basis for its decision. Tax teams whose effective tax rate calculations or dividend repatriation models assumed 5% should correct them to 10%.
Transfer Pricing in Pharma and Chemicals
Swiss pharmaceutical companies (Novartis, Roche, Sandoz) face intense transfer pricing scrutiny in India. Indian tax authorities have challenged royalty payments, management fee allocations, and cost-sharing arrangements. Key risk areas include royalty rates on patented molecules and brand names, allocation of group R&D costs, pricing of active pharmaceutical ingredients supplied by the Swiss parent, and marketing intangible contributions. Maintain robust economic analysis with Indian and global comparables.
Permanent Establishment Risk for Engineering Services
Swiss engineering companies (ABB, Sulzer, Bühler) often deploy engineers to India for project implementation. If these deployments exceed the duration threshold under the DTAA (typically 183 days in any 12-month period), a service PE may be established. The Swiss parent's service income then becomes taxable in India at 35%. Track deployment durations carefully and structure service agreements to minimize PE risk.
Equalization Levy on Digital Services
If a Swiss company provides digital advertising services or operates a digital platform accessed by Indian users, the equalization levy previously applied (6% on digital advertising abolished April 2025; 2% on e-commerce abolished August 2024). Neither levy is currently in force. Swiss technology companies with digital revenue from India should assess any equalization levy exposure for periods before these abolition dates.
Currency Volatility (CHF/INR)
The Swiss franc is one of the world's strongest currencies. CHF/INR volatility affects the Indian subsidiary's foreign exchange gains/losses, which impact taxable income. Intercompany loans denominated in CHF can create significant forex gains or losses that must be reported in the Indian tax return. Consider hedging strategies and document the business rationale for currency choices in intercompany agreements.
Why Choose Beacon Filing
We provide comprehensive tax compliance for Swiss companies operating in India. Our team understands the India-Switzerland DTAA and its MFN clause, Swiss pharma transfer pricing challenges, and the complexities of large multinational compliance.
- Corporate tax filing — ITR-6 preparation, advance tax computation, and e-filing
- Tax advisory — DTAA structuring, PE risk assessment, and withholding optimization
- Compliance outsourcing — GST, TDS, FEMA reporting, and statutory audit coordination
We work with Swiss companies across pharmaceuticals, chemicals, engineering, financial services, and food and beverage.
WhatsApp: +91 782 783 9299 | Email: [email protected]
Frequently Asked Questions
What changed with the MFN clause suspension in December 2024?
Switzerland stopped applying the MFN clause of the India-Switzerland DTAA unilaterally for dividends due from January 1, 2025. This affects only Swiss dividends paid to Indian residents, which went back from 5% to 10%. India never applied the 5% rate, following the Indian Supreme Court's October 2023 ruling that MFN benefits require explicit government notification under the Income Tax Act, so dividends, interest, royalties and FTS paid from India to Switzerland remain at 10%.
Does the 10% dividend rate apply to all dividends declared from January 2025?
Yes. Dividends declared on or after January 1, 2025, by Indian companies to Swiss shareholders are subject to 10% withholding under the DTAA. Dividends declared before that date were also subject to 10%, because India never applied the 5% MFN rate.
How do Swiss companies claim DTAA benefits in India?
The Swiss entity must obtain a Tax Residency Certificate from the cantonal tax office (Steueramt) and file Form 41 electronically on the Indian Income Tax portal. These documents must be in place before filing the ITR. Without them, Indian domestic rates of 20% apply on dividends, interest, royalties, and FTS.
Are Swiss companies subject to transfer pricing scrutiny in India?
Yes. Swiss companies with intercompany transactions exceeding Rs 1 crore must maintain transfer pricing documentation under section 171 of the Income-tax Act, 2025 and file Form 48 by October 31, a month before the November 30 return deadline. Indian authorities are particularly active in auditing Swiss pharma and chemicals companies on royalty rates and management fee allocations.
What is the equalization levy and does it affect Swiss companies?
The equalization levy had two components: 6% on digital advertising (EL 1.0) and 2% on e-commerce supply of goods or services (EL 2.0) by non-residents without a PE in India. Both have been abolished — EL 2.0 effective August 2024 and EL 1.0 effective April 2025 — so neither levy is currently in force, though prior-period obligations before the respective abolition dates may still need to be settled. Neither levy was ever covered by the DTAA or creditable against Swiss tax.
Can a Swiss company still benefit from the India-Switzerland BIT?
Yes. The India-Switzerland BIT remains in force and provides investment protection including fair and equitable treatment, protection against expropriation, and investor-state dispute settlement. However, India has been renegotiating its BIT framework, so future changes are possible.